Image Source: Unsplash
The Biden administration is laying down strategies to help Americans limit their tobacco use, thus affecting the shares of cigarettes and other tobacco products in the process. Altria shares went down by more than 6%, while British American Tobacco plummeted by 2% when a report revealed the administration’s plans to reduce nicotine levels in cigarettes. However, these companies are also facing another threat because the Food and Drug Administration has also proposed rules to reduce smoking in America.
Though these are still proposals, people who invested in tobacco companies already looked for new investment strategies. In fact, many people invested in bullish nicotine pouch shares to secure guaranteed returns in the next few years.
The Impact of the Proposed Tobacco Product Regulations
Tobacco companies like Altria, British American Tobacco, and Philip Morris International, showed impressive stock performance in the past decade. However, things could change in a few years due to the Biden administration’s proposal to limit nicotine levels in cigarettes. Likewise, the FDA proposed a rule that seeks to prohibit menthol and other flavors in cigarettes last April, which can lead to a significant decrease in the shares of tobacco companies.
Though these are mere proposals, it’s worth noting that Altria stocks fell by 10% when the FDA banned Juul vaping products last June. The cigarette producer acquired a 35% stake in Juul Labs back in 2018. Unfortunately, the e-cigarette faced scrutiny for marketing to teenagers and eventually didn’t make the cut to FDA’s product review in 2020. Many investors ended up selling their stocks because Altria’s $12.8 billion stake was reduced to $1.6 billion.
However, Philip Morris International remains a high dividend yield stock because the company ventured into smoke-free nicotine products. Though the company is known for Malboro and other cigarettes, Philip Morris launched the nicotine pouch Shiro and other smoke-free brands over the past decade. This was a necessary move because cigarette sales volumes plummeted from 635.6 billion in 1981 to 203.7 billion in 2020. More than 50% of their revenue in countries like Greece, Japan, and the Czech Republic comes from smoke-free businesses, which could be the same case for the US in the future.
The Rapid Growth of Nicotine Pouches
The Biden administration and the FDA have not approved the proposals yet. However, the decline in tobacco product shares and the increase in the performance of nicotine pouches are very telling for investors.
Even Philip Morris International expanded its market to a nicotine pouch called Shiro, and there’s a good reason why investors should follow suit with nicotine pouches. Prilla shows that ZYN nicotine pouches are becoming a hit among American consumers who are trying to reduce their tobacco intake or avoid the taste of tobacco. After all, the Swedish Match brand developed these pouches with the American consumer in mind, which is why there is a huge demand for these types of nicotine products in the country since they were launched in 2014.
Though ZYN is already facing stiff competition in the US, Swedish Match reports that the nicotine pouches drove the companies’ strong financial performance in the US and in Scandinavia. So even if the product lost market share in the US a year earlier, the brand’s fourth-quarter operating profit for 2021 grew by 15%, which matches the market expectations for the shares. As a result, Swedish Match raised its dividends due to the impressive rise in the nicotine pouches’ quarterly profits.
Overall, the market size of nicotine pouches seem bullish for the next few years. Experts predict that the market shares for the nicotine replacement product will reach $23 billion by 2023, which could further increase once the government fully implements cigarette regulations.




Comments
Log in or sign up to join the conversation.